“IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 9, no. 1, Jan. 2017, p. e2017010, https://doi.org/10.4084/mjhid.2017.010.